scholarly journals Female sexual dysfunction in androgenetic alopecia: Case-control study

2016 ◽  
Vol 10 (7-8) ◽  
pp. 251 ◽  
Author(s):  
Eyup Burak Sancak ◽  
Sevilay Oguz ◽  
Tugba Akbulut ◽  
Aysegul Uludag ◽  
Alpaslan Akbas ◽  
...  

<p><strong>Introduction:</strong> We sought to evaluate the association of female sexual dysfunction (FSD) with adrogenetic alopecia (AGA) and metabolic syndrome (MetS) in premenopausal women.</p><p><strong>Methods:</strong> From December 2013 to June 2015, we performed a case-control, prospective study of 115 patients with AGA and 97 age-matched control patients without AGA from among premenopausal<br />women who visited dermatology clinics of the two reference hospitals. Comprehensive history, anthropometric measurements, and questionnaire administration were performed for each of the total of 212 women. The Female Sexual Function Index (FSFI) was used to assess the key dimensions of female sexual function. AGA was assessed and graded by an experienced dermatologist according to Ludwig’s classification. The MetS assessment was made according to the NCEP-ATP III criteria.</p><p><strong>Results:</strong> In univariate analysis, age, weight, waist circumference, hip circumference, waist-to-hip ratio, body mass index (BMI), AGA, MetS, cardiovascular event, marital status, hypertension, high fasting plasma glucose, high triglyceride, large waist, total testosterone, and free testosterone were associated with presence of FSD. In logistic regression analysis, age (odds ratio [OR] 1.21, 95% confidence interval [CI] 1.13‒1.30; p&lt;0.001), AGA (OR 3.42, 95% CI 1.31‒8.94; p=0.017), MetS (OR 5.39, 95% CI 1.34‒21.62; p=0.012), and free testosterone (OR 0.18, 95% CI 0.09‒0.37; p&lt;0.001) were independently associated with FSD.</p><p><strong>Conclusions:</strong> Our study suggests that age, AGA, MetS, and free testosterone may have strong impact on sexual function in premenopausal women. Further studies with population-based and longitudinal design should be conducted to confirm this finding.</p>

Author(s):  
Firoozeh Mirzaee ◽  
Atefeh Ahmadi ◽  
Zahra Zangiabadi ◽  
Moghaddameh Mirzaee

Abstract Introduction Sexual function is a multidimensional phenomenon that is affected by many biological and psychological factors. Cognitive-behavioral sex therapies are among the most common nonpharmacological approaches to psychosexual problems. The purpose of the present study was to investigate the effectiveness of psychoeducational and cognitive-behavioral counseling on female sexual dysfunction. Methods The present study was a clinical trial with intervention and control groups. The study population consisted of women referring to the general clinic of a governmental hospital in Iran. After completing the demographic questionnaire and Female Sexual Function Index (FSFI), those who obtained the cutoff score ≤ 28 were contacted and invited to participate in the study. Convenience sampling method was used and 35 subjects were randomly allocated for each group. Eight counseling sessions were held for the intervention group (two/week/1.5 hour). Post-test was taken from both groups after 1 month, and the results were statistically analyzed by PASW Statistics for Windows, Version 18 (SPSS Inc., Chicago, IL, USA). Results The total mean scores of FSFI and the subscales of sexual desire, arousal, orgasm, and satisfaction were significantly higher in the intervention group than in the control group after the intervention. In addition, postintervention pain mean scores in the intervention group were significantly lower than in the control group (p < 0.05). Conclusion The results of the present study indicate that psychoeducational cognitive-behavioral counseling is effective in improving female sexual function. It is recommended to compare the effects of psychoeducational cognitive-behavioral counseling on sexual dysfunctions of couples and with a larger sample size in future research.


2015 ◽  
Vol 2015 ◽  
pp. 1-5 ◽  
Author(s):  
Ho Seok Chung ◽  
Insang Hwang ◽  
Kyung Jin Oh ◽  
Mi Na Lee ◽  
Kwangsung Park

This study investigated whether Korean red ginseng (KRG) extracts could improve sexual function in premenopausal women. Forty-one premenopausal women participated in this placebo-controlled, double-blind, and crossover clinical study with administration of either three ginseng capsules (1 g per capsule) or placebo daily. After 8 weeks of medication of KRG or placebo, medication was changed for the subjects to placebo or KRG after 2 weeks of washout period. The efficacy of KRG extracts was measured by using Female Sexual Function Index (FSFI).Results. Twenty-three women completed the study. Total FSFI scores increased after KRG treatment (from20.13±2.87to23.98±4.10,p=0.015) and placebo treatment (from20.06±2.64to23.78±3.28,p=0.003). However, this change was not significantly different between the two groups (p=0.702). KRG treatment significantly improved sexual desire, arousal, orgasm, and satisfaction domains; however, there was no treatment effect compared with placebo. There was a case of gastric discomfort after taking KRG extracts. Oral administration of KRG extracts improved sexual function in premenopausal women; however, there were no statistical significant changes compared to placebo. It implies that KRG extracts have a substantial placebo effect in premenopausal women with sexual dysfunction.


2020 ◽  
Author(s):  
Zaina Alazawi ◽  
Ola Alqudah ◽  
Ahmad Al-Bashaireh

The aims of this study are to determine the prevalence of sexual dysfunction and to examine the relationships of sexual function and psychological factors of depression and anxiety and diabetes-related factors in Jordanian women with type 2 diabetes mellitus. This study employed a cross-sectional, descriptive, correlational design. All eligible participants with type 2 diabetes mellitus were consequently recruited from primary care centers. All enrolled participants were asked to complete questionnaires: Arabic version of the Female Sexual Function Index, Beck Depression Inventory-II, Beck Anxiety Inventory, and demographic questionnaires. Physical and biological measures were collected from the patient's medical records. 107 women with type 2 diabetes mellitus were recruited with a mean of age of 52.46±8.38 years. The prevalence of female sexual dysfunction was 94.4%. Regarding the mean scores of the Arabic version of the Female Sexual Function Index domains, the highest mean score was for pain (5.09±1.51), and the lowest mean score was for sexual arousal (2.44±1.28). This study found significant inverse relationships between female sexual function and age (r= -0.340, P<0.01), duration of diabetes (r= -0.211, P=0.029), fasting blood sugar (r= -0.234, P=0.015), anxiety (r= -0.375, P<0.01), and depression (r= -0.480, P<0.01). Our study found female sexual dysfunction is widely prevalent in Jordanian women with type 2 diabetes mellitus (94.4%). There were significant correlations between anxiety, depression, and female sexual function among women with type 2 diabetes mellitus.


Author(s):  
Cecilia Raccagni ◽  
Elisabetta Indelicato ◽  
Victoria Sidoroff ◽  
Martin Daniaux ◽  
Angelika Bader ◽  
...  

Abstract Purpose The diagnosis of probable multiple system atrophy relies on the presence of severe cardiovascular or urogenital autonomic failure. Erectile dysfunction is required to fulfil the latter criterion in men, whereas no corresponding item is established for women. In this study, we aimed to investigate sexual dysfunction in women with multiple system atrophy. Methods We administered the Female Sexual Function Index questionnaire and interviewed women with multiple system atrophy and age-matched controls regarding the presence of “genital hyposensitivity.” Results We recruited 25 women with multiple system atrophy and 42 controls. Female Sexual Function Index scores in sexually active women with multiple system atrophy were significantly lower (multiple system atrophy = 10; 15.4, 95% CI [10.1, 22.1], controls = 37; 26.1 [24.1, 28.1], p = 0.0004). The lowest scores concerned the domains of desire, arousal and lubrication. Genital hyposensitivity was reported by 56% of the patients with multiple system atrophy and 9% controls (p < 0.0001). Conclusions Sexual dysfunction is highly prevalent in women with multiple system atrophy. Screening for disturbances in specific sexual domains should be implemented in the clinical evaluation of women with suggestive motor symptoms.


2016 ◽  
Vol 13 (5) ◽  
pp. 733-759 ◽  
Author(s):  
Roy J. Levin ◽  
Stephanie Both ◽  
Janniko Georgiadis ◽  
Tuuli Kukkonen ◽  
Kwangsung Park ◽  
...  

Sexual Health ◽  
2014 ◽  
Vol 11 (3) ◽  
pp. 240 ◽  
Author(s):  
Samy Hanafy ◽  
Neveen E. Srour ◽  
Taymour Mostafa

Background Pregnancy is a special period in the life of women characterised by physical, hormonal and psychological changes that, in conjugation with social and cultural influences, could affect women’s sexuality as well as couples’ sexual relationships. This cross-sectional study aimed to evaluate female sexual dysfunction (FSD) among the three pregnancy trimesters. Methods: A total of 300 healthy heterosexual pregnant Egyptian women with stable marital relationships were included. The Female Sexual Function Index (FSFI) questionnaire was used as a standard method for measuring female sexual function in each pregnancy trimester. Results: There was no significant relationship between FSD and women’s education, work, gravidity and parity. The incidence of FSD demonstrated significant alterations throughout pregnancy, being 68% in the first trimester, decreasing in the second trimester to 51% and increasing to 72% in the third trimester. Sexual desire decreased in the first trimester, was variable in the second trimester and decreased at the end of the third trimester (3.5 ± 1.2, 3.7 ± 1.2 and 3.4 ± 1.1 respectively). Sexual satisfaction declined significantly in the first trimester compared with the second and the third trimesters (4.2 ± 1.1, 4.8 ± 0.8 and 4.6 ± 1.0 respectively). Scores for the arousal, lubrication and orgasm domains were significantly decreased in the third trimester, where pain was increased in the second trimester compared with the first and third trimesters. Conclusion: Female sexual function is affected during pregnancy, with a significant change in all Female Sexual Function Index domains, especially in the first and third trimesters.


Sign in / Sign up

Export Citation Format

Share Document